Find Oligonucleotide manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

0

JDMF

0

EU WC

0

KDMF

0

NDC API

0

VMF

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

0

FDA Orange Book

0

Europe

0

Canada

0

Australia

0

South Africa

0

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Acacccaattctgaaaatgg, Antisense oligo to hiv-1 5349-5368, 104053-06-7, Oligonucleotides
Molecular Formula
C195H245N78O114P19
Molecular Weight
6094  g/mol
InChI Key
JLCPHMBAVCMARE-UHFFFAOYSA-N

Oligonucleotide
Polymers made up of a few (2-20) nucleotides. In molecular genetics, they refer to a short sequence synthesized to match a region where a mutation is known to occur, and then used as a probe (OLIGONUCLEOTIDE PROBES). (Dorland, 28th ed)
1 2D Structure

Oligonucleotide

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate
2.1.2 InChI
InChI=1S/C195H245N78O114P19/c1-78-35-259(192(288)250-177(78)276)133-22-89(110(357-133)47-337-396(308,309)376-90-23-134(260-36-79(2)178(277)251-193(260)289)358-111(90)48-338-400(316,317)381-94-27-139(265-69-230-149-160(203)214-61-222-168(149)265)362-115(94)52-342-402(320,321)383-96-29-141(267-71-232-151-162(205)216-63-224-170(151)267)361-114(96)51-341-394(304,305)374-88-21-132(258-14-9-126(200)243-191(258)287)353-106(88)43-333-390(296,297)370-85-18-129(255-11-6-123(197)240-188(255)284)352-105(85)42-332-391(298,299)371-86-19-130(256-12-7-124(198)241-189(256)285)355-108(86)45-335-399(314,315)380-93-26-138(264-68-229-148-159(202)213-60-221-167(148)264)360-113(93)50-340-393(302,303)373-84-17-128(254-10-5-122(196)239-187(254)283)351-104(84)41-331-389(294,295)369-83-16-137(349-102(83)39-274)263-67-228-147-158(201)212-59-220-166(147)263)375-395(306,307)334-44-107-87(20-131(354-107)257-13-8-125(199)242-190(257)286)372-392(300,301)336-46-109-91(24-135(356-109)261-37-80(3)179(278)252-194(261)290)377-398(312,313)348-58-121-101(34-146(368-121)273-77-238-157-176(273)246-186(211)249-183(157)282)387-406(328,329)346-56-119-99(32-144(366-119)270-74-235-154-165(208)219-66-227-173(154)270)386-405(326,327)345-55-118-98(31-143(365-118)269-73-234-153-164(207)218-65-226-172(153)269)385-404(324,325)344-54-117-97(30-142(364-117)268-72-233-152-163(206)217-64-225-171(152)268)384-403(322,323)343-53-116-95(28-140(363-116)266-70-231-150-161(204)215-62-223-169(150)266)382-401(318,319)339-49-112-92(25-136(359-112)262-38-81(4)180(279)253-195(262)291)378-397(310,311)347-57-120-100(33-145(367-120)272-76-237-156-175(272)245-185(210)248-182(156)281)379-388(292,293)330-40-103-82(275)15-127(350-103)271-75-236-155-174(271)244-184(209)247-181(155)280/h5-14,35-38,59-77,82-121,127-146,274-275H,15-34,39-58H2,1-4H3,(H,292,293)(H,294,295)(H,296,297)(H,298,299)(H,300,301)(H,302,303)(H,304,305)(H,306,307)(H,308,309)(H,310,311)(H,312,313)(H,314,315)(H,316,317)(H,318,319)(H,320,321)(H,322,323)(H,324,325)(H,326,327)(H,328,329)(H2,196,239,283)(H2,197,240,284)(H2,198,241,285)(H2,199,242,286)(H2,200,243,287)(H2,201,212,220)(H2,202,213,221)(H2,203,214,222)(H2,204,215,223)(H2,205,216,224)(H2,206,217,225)(H2,207,218,226)(H2,208,219,227)(H,250,276,288)(H,251,277,289)(H,252,278,290)(H,253,279,291)(H3,209,244,247,280)(H3,210,245,248,281)(H3,211,246,249,282)
2.1.3 InChI Key
JLCPHMBAVCMARE-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)OC3CC(OC3COP(=O)(O)OC4CC(OC4COP(=O)(O)OC5CC(OC5COP(=O)(O)OC6CC(OC6COP(=O)(O)OC7CC(OC7COP(=O)(O)OC8CC(OC8COP(=O)(O)OC9CC(OC9COP(=O)(O)OC1CC(OC1COP(=O)(O)OC1CC(OC1COP(=O)(O)OC1CC(OC1COP(=O)(O)OC1CC(OC1CO)N1C=NC2=C(N=CN=C21)N)N1C=CC(=NC1=O)N)N1C=NC2=C(N=CN=C21)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C(N=CN=C21)N)N1C=C(C(=O)NC1=O)C)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)O
2.2 Synonyms
2.2.1 MeSH Synonyms

1. Oligonucleotide

2. Oligonucleotides

2.2.2 Depositor-Supplied Synonyms

1. Acacccaattctgaaaatgg

2. Antisense Oligo To Hiv-1 5349-5368

3. 104053-06-7

4. Oligonucleotides

2.3 Create Date
2007-07-04
3 Chemical and Physical Properties
Molecular Weight 6094 g/mol
Molecular Formula C195H245N78O114P19
XLogP3-37.7
Hydrogen Bond Donor Count44
Hydrogen Bond Acceptor Count152
Rotatable Bond Count116
Exact Mass6093.0853594 g/mol
Monoisotopic Mass6091.0786497 g/mol
Topological Polar Surface Area2590 Ų
Heavy Atom Count406
Formal Charge0
Complexity17800
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count60
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

API SUPPLIERS

read-more
read-more

01

Nitto Denko Avecia

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PEGS Boston Summit
Not Confirmed
arrow

Nitto Denko Avecia

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PEGS Boston Summit
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

02

Nitto Denko Avecia

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PEGS Boston Summit
Not Confirmed
arrow

Nitto Denko Avecia

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PEGS Boston Summit
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

03

Nitto Denko Avecia

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PEGS Boston Summit
Not Confirmed
arrow

Nitto Denko Avecia

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PEGS Boston Summit
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

04

Nitto Denko Avecia

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PEGS Boston Summit
Not Confirmed
arrow

Nitto Denko Avecia

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PEGS Boston Summit
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

05

Nitto Denko Avecia

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PEGS Boston Summit
Not Confirmed
arrow

Nitto Denko Avecia

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PEGS Boston Summit
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

06

Nitto Denko Avecia

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PEGS Boston Summit
Not Confirmed
arrow

Nitto Denko Avecia

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PEGS Boston Summit
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

07

NITTO DENKO CORP

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PEGS Boston Summit
Not Confirmed
arrow

NITTO DENKO CORP

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PEGS Boston Summit
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

08

NITTO DENKO CORP

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PEGS Boston Summit
Not Confirmed
arrow

NITTO DENKO CORP

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PEGS Boston Summit
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

09

NITTO DENKO CORP

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PEGS Boston Summit
Not Confirmed
arrow

NITTO DENKO CORP

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PEGS Boston Summit
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

10

KriSan Biotech

Taiwan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PEGS Boston Summit
Not Confirmed
arrow

KriSan Biotech

Taiwan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PEGS Boston Summit
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

PEGS Boston Summit
Not Confirmed

02

PEGS Boston Summit
Not Confirmed

02

PEGS Boston Summit
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 16073

Submission : 2002-07-29

Status : Inactive

Type : II

blank

03

PEGS Boston Summit
Not Confirmed

03

PEGS Boston Summit
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 16836

Submission : 2003-09-12

Status : Inactive

Type : II

blank

04

PEGS Boston Summit
Not Confirmed

04

PEGS Boston Summit
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 13803

Submission : 1998-10-23

Status : Inactive

Type : II

blank

05

PEGS Boston Summit
Not Confirmed

05

PEGS Boston Summit
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 16631

Submission : 2003-06-10

Status : Inactive

Type : II

blank

06

PEGS Boston Summit
Not Confirmed

07

Nitto Denko Corp

Japan

USDMF

arrow
PEGS Boston Summit
Not Confirmed

07

PEGS Boston Summit
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 21924

Submission : 2008-08-29

Status : Inactive

Type : II

blank

08

Nitto Denko Corp

Japan

USDMF

arrow
PEGS Boston Summit
Not Confirmed

08

PEGS Boston Summit
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 16355

Submission : 2003-01-14

Status : Inactive

Type : II

blank

09

Nitto Denko Corp

Japan

USDMF

arrow
PEGS Boston Summit
Not Confirmed

09

PEGS Boston Summit
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 12152

Submission : 1996-10-02

Status : Inactive

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Oligonucleotide

About the Company : KriSan Biotech is a Taiwan company and was founded in August, 2015. KriSan Biotech has a group of professional team with 15+ years API experiences and provides world-class service...

KriSan Biotech is a Taiwan company and was founded in August, 2015. KriSan Biotech has a group of professional team with 15+ years API experiences and provides world-class services to support process and analytical method R&D and validation, CGMP production, CMC compiling and regulatory consultation. KriSan Biotech offers high technical barriers APIs of small molecule, peptide, peptide-drug conjugate (PDC), oligonucleotide, and complex drug substances to pharmaceutical industries worldwide for both Generic and Contract Development and Manufacturing (CDMO) market.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more
  • Development Update

Details:

Oligonucleotides is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.


Lead Product(s): Oligonucleotide,Phosphorothioate

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Undisclosed

Sponsor: Immunalgia Therapeutics

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable March 15, 2024

blank

01

Ministry of Public Health, La Rioja

Country
arrow
PEGS Boston Summit
Not Confirmed

Ministry of Public Health, La Rioja

Country
arrow
PEGS Boston Summit
Not Confirmed

Lead Product(s) : Oligonucleotide,Phosphorothioate

Therapeutic Area : Undisclosed

Highest Development Status : Phase I

Partner/Sponsor/Collaborator : Immunalgia Therapeutics

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Oligonucleotides is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Undisclosed

Upfront Cash : Inapplicable

March 15, 2024

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Looking for 104053-06-7 / Oligonucleotide API manufacturers, exporters & distributors?

Oligonucleotide manufacturers, exporters & distributors 1

54

PharmaCompass offers a list of Oligonucleotide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Oligonucleotide manufacturer or Oligonucleotide supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Oligonucleotide manufacturer or Oligonucleotide supplier.

API | Excipient name

Oligonucleotide

Synonyms

Acacccaattctgaaaatgg, Antisense oligo to hiv-1 5349-5368, 104053-06-7, Oligonucleotides

Cas Number

104053-06-7

About Oligonucleotide

Polymers made up of a few (2-20) nucleotides. In molecular genetics, they refer to a short sequence synthesized to match a region where a mutation is known to occur, and then used as a probe (OLIGONUCLEOTIDE PROBES). (Dorland, 28th ed)

Oligonucleotide Manufacturers

A Oligonucleotide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oligonucleotide, including repackagers and relabelers. The FDA regulates Oligonucleotide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oligonucleotide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Oligonucleotide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Oligonucleotide Suppliers

A Oligonucleotide supplier is an individual or a company that provides Oligonucleotide active pharmaceutical ingredient (API) or Oligonucleotide finished formulations upon request. The Oligonucleotide suppliers may include Oligonucleotide API manufacturers, exporters, distributors and traders.

click here to find a list of Oligonucleotide suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Oligonucleotide USDMF

A Oligonucleotide DMF (Drug Master File) is a document detailing the whole manufacturing process of Oligonucleotide active pharmaceutical ingredient (API) in detail. Different forms of Oligonucleotide DMFs exist exist since differing nations have different regulations, such as Oligonucleotide USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Oligonucleotide DMF submitted to regulatory agencies in the US is known as a USDMF. Oligonucleotide USDMF includes data on Oligonucleotide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Oligonucleotide USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Oligonucleotide suppliers with USDMF on PharmaCompass.

Oligonucleotide GMP

Oligonucleotide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Oligonucleotide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Oligonucleotide GMP manufacturer or Oligonucleotide GMP API supplier for your needs.

Oligonucleotide CoA

A Oligonucleotide CoA (Certificate of Analysis) is a formal document that attests to Oligonucleotide's compliance with Oligonucleotide specifications and serves as a tool for batch-level quality control.

Oligonucleotide CoA mostly includes findings from lab analyses of a specific batch. For each Oligonucleotide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Oligonucleotide may be tested according to a variety of international standards, such as European Pharmacopoeia (Oligonucleotide EP), Oligonucleotide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oligonucleotide USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty